Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers.
de Brouwer R, Te Rijdt WP, Hoorntje ET, Amin A, Asselbergs FW, Cox MGPJ, van der Heijden JF, Hillege H, Karper JC, Mahmoud B, van der Meer P, Oomen A, Te Riele ASJM, Silljé HHW, Tan HL, van Tintelen JP, van Veldhuisen DJ, Westenbrink BD, Wiesfeld ACP, Willems TP, van der Zwaag PA, Wilde AAM, de Boer RA, van den Berg MP. de Brouwer R, et al. Eur Heart J. 2023 Oct 21;44(40):4284-4287. doi: 10.1093/eurheartj/ehad292. Eur Heart J. 2023. PMID: 37210081 Free PMC article. No abstract available.
Surviving the first COVID-19 wave and learning lessons for the second.
de Brouwer R, van Veldhuisen DJ, de Boer RA. de Brouwer R, et al. Among authors: de boer ra. Eur J Heart Fail. 2020 Jun;22(6):975-977. doi: 10.1002/ejhf.1938. Epub 2020 Jul 4. Eur J Heart Fail. 2020. PMID: 32564415 Free PMC article. No abstract available.
Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers-reaching the frontiers of individual risk prediction.
Verstraelen TE, van Lint FHM, Bosman LP, de Brouwer R, Proost VM, Abeln BGS, Taha K, Zwinderman AH, Dickhoff C, Oomen T, Schoonderwoerd BA, Kimman GP, Houweling AC, Gimeno-Blanes JR, Asselbergs FW, van der Zwaag PA, de Boer RA, van den Berg MP, van Tintelen JP, Wilde AAM. Verstraelen TE, et al. Among authors: de boer ra, de brouwer r. Eur Heart J. 2021 Jul 31;42(29):2842-2850. doi: 10.1093/eurheartj/ehab294. Eur Heart J. 2021. PMID: 34113975 Free PMC article.
Rationale and design of the PHOspholamban RElated CArdiomyopathy intervention STudy (i-PHORECAST).
Te Rijdt WP, Hoorntje ET, de Brouwer R, Oomen A, Amin A, van der Heijden JF, Karper JC, Westenbrink BD, Silljé HHW, Te Riele ASJM, Wiesfeld ACP, van Gelder IC, Willems TP, van der Zwaag PA, van Tintelen JP, Hillege JH, Tan HL, van Veldhuisen DJ, Asselbergs FW, de Boer RA, Wilde AAM, van den Berg MP. Te Rijdt WP, et al. Among authors: de boer ra, de brouwer r. Neth Heart J. 2022 Feb;30(2):84-95. doi: 10.1007/s12471-021-01584-5. Epub 2021 Jun 18. Neth Heart J. 2022. PMID: 34143416 Free PMC article.
Optimal echocardiographic assessment of myocardial dysfunction for arrhythmic risk stratification in phospholamban mutation carriers.
Taha K, Verstraelen TE, de Brouwer R, de Bruin-Bon RHACM, Cramer MJ, Te Rijdt WP, Bouma BJ, de Boer RA, Doevendans PA, Asselbergs FW, Wilde AAM, van den Berg MP, Teske AJ. Taha K, et al. Among authors: de boer ra, de bruin bon rhacm, de brouwer r. Eur Heart J Cardiovasc Imaging. 2022 Oct 20;23(11):1492-1501. doi: 10.1093/ehjci/jeab178. Eur Heart J Cardiovasc Imaging. 2022. PMID: 34516619 Free PMC article.
Sex-specific aspects of phospholamban cardiomyopathy: The importance and prognostic value of low-voltage electrocardiograms.
de Brouwer R, Meems LMG, Verstraelen TE, Mahmoud B, Proost V, Wilde AAM, Bosman LP, van Drie E, van der Zwaag PA, van Tintelen JP, Houweling AC, van den Berg MP, de Boer RA. de Brouwer R, et al. Among authors: de boer ra. Heart Rhythm. 2022 Mar;19(3):427-434. doi: 10.1016/j.hrthm.2021.11.009. Epub 2021 Nov 9. Heart Rhythm. 2022. PMID: 34767988 Free article.
Exploring the Correlation Between Fibrosis Biomarkers and Clinical Disease Severity in PLN p.Arg14del Patients.
van der Voorn SM, Bourfiss M, Te Riele ASJM, Taha K, Vos MA, de Brouwer R, Verstraelen TE, de Boer RA, Remme CA, van Veen TAB. van der Voorn SM, et al. Among authors: de boer ra, de brouwer r. Front Cardiovasc Med. 2022 Jan 13;8:802998. doi: 10.3389/fcvm.2021.802998. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35097021 Free PMC article.
Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein Aggregation.
Eijgenraam TR, Stege NM, Oliveira Nunes Teixeira V, de Brouwer R, Schouten EM, Grote Beverborg N, Sun L, Später D, Knöll R, Hansson KM, Amilon C, Janzén D, Yeh ST, Mullick AE, van der Meer P, de Boer RA, Silljé HHW. Eijgenraam TR, et al. Among authors: de brouwer r. Int J Mol Sci. 2022 Feb 22;23(5):2427. doi: 10.3390/ijms23052427. Int J Mol Sci. 2022. PMID: 35269571 Free PMC article.
Phenotypic and Genetic Factors Associated with Absence of Cardiomyopathy Symptoms in PLN:c.40_42delAGA Carriers.
Lopera-Maya EA, Li S, de Brouwer R, Nolte IM, van Breen J; Netherlands A. C. M./P. L. N. Registry; Lifelines Cohort Study; Jongbloed JDH, Swertz MA, Snieder H, Franke L, Wijmenga C, de Boer RA, Deelen P, van der Zwaag PA, Sanna S. Lopera-Maya EA, et al. Among authors: de brouwer r. J Cardiovasc Transl Res. 2023 Dec;16(6):1251-1266. doi: 10.1007/s12265-022-10347-5. Epub 2023 Jan 9. J Cardiovasc Transl Res. 2023. PMID: 36622581 Free PMC article.
17 results